Mucocele of salivary gland

Summary

Mucocele of salivary gland (MONDO:0001600) is a disease. A subtype of salivary gland disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	mucocele of salivary gland
Mondo ID	MONDO:0001600
MeSH	D011900
DOID	DOID:12904
ICD-10-CM	K11.6
ICD-11	48444833
SNOMED CT	69825009
UMLS	C0026686
MedGen	10117
Is cancer (heuristic)	no

Also known as: mucous retention cyst of salivary gland · ranula · salivary cyst · salivary gland mucocele

Disease family

This is a subtype of salivary gland disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › mouth disorder › salivary gland disorder › mucocele of salivary gland

Related subtypes (8): submandibular gland disorder, benign lymphoepithelial lesion of salivary gland, parotid disorder, necrotizing sialometaplasia, sialadenitis, sialolithiasis, Sjogren syndrome, tumor of salivary gland

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.